c Hypervirulent invasive group A streptococcus (GAS) isolates inhibit neutrophil infiltration more than pharyngitis isolates do, and the molecular basis of this difference is not well understood. This study was designed to first determine whether natural null mutation of the two-component regulatory system CovRS is responsible for the enhancement of the inhibition of neutrophil recruitment seen in hypervirulent GAS. Next, we examined the role of CovRS-regulated interleukin-8/CXC chemokine peptidase (SpyCEP), C5a peptidase (ScpA), and platelet-activating factor acetylhydrolase (SsE) in the enhanced innate immune evasion. Invasive isolate MGAS5005 induces less neutrophil infiltration and produced a greater lesion area than pharyngitis isolate MGAS2221 in subcutaneous infections of mice. It is known that MGAS5005, but not MGAS2221, has a natural 1-bp deletion in the covS gene. Replacement of covS ⌬1bp in MGAS5005 with wild-type covS resulted in the MGAS2221 phenotype. Deletion of covS from MGAS2221 resulted in the MGAS5005 phenotype. Tests of single, double, and triple deletion mutants of the MGAS5005 sse, spyCEP, and scpA genes found that SsE plays a more important role than SpyCEP and ScpA in the inhibition of neutrophil recruitment and that SsE, SpyCEP, and ScpA do not have synergistic effects on innate immune evasion by MGAS5005. Deletion of sse, but not spyCEP or scpA, of MGAS2221 enhances neutrophil recruitment. Thus, covS null mutations can cause substantial inhibition of neutrophil recruitment by enhancing the expression of the chemoattractant-degrading virulence factors, and SsE, but not SpyCEP or ScpA, is required for CovRS-regulated GAS inhibition of neutrophil infiltration.
G
roup A streptococcus (GAS) commonly causes relatively mild pharyngitis and superficial skin infections. This major human pathogen also causes approximately 10,000 cases of severe invasive infections, such as necrotizing fasciitis, sepsis, and toxic shock syndrome, annually in the United States (1) . Necrotizing fasciitis is a rapidly progressive infection of the skin, subcutaneous and deep soft tissue, and muscle and leads to systemic dissemination (2) . Innate immune invasion by hypervirulent GAS plays a critical role in severe invasive infections. Neutrophil infiltrate is sparse in streptococcal necrotizing fasciitis (3) (4) (5) . This severe inhibition of neutrophil recruitment can be modeled in experimental animal infections with severe invasive GAS isolates (3, 6, 7) but not pharyngitis isolates (7) . Peptidases ScpA and SpyCEP (also known as ScpC) produced by GAS degrade the chemotactic C5a peptide and interleukin-8 (IL-8)/CXC chemokines, respectively, and are believed to contribute to inhibition of neutrophil recruitment (3, (8) (9) (10) (11) . The secreted esterase SsE of GAS, a protective antigen (12) , targets platelet-activating factor to critically contribute to GAS inhibition of neutrophil recruitment and skin invasion (7, 13) . GAS also resists phagocytosis by neutrophils through the hyaluronic acid capsule and surface M protein (14, 15) , kills neutrophils through streptolysins S and O (16, 17) , and escapes neutrophil extracellular traps through DNases (18) . Despite these advances, the molecular basis of innate immune evasion by hypervirulent GAS isolates is not fully understood. Furthermore, it is not known whether SpyCEP and ScpA also critically contribute to the inhibition of neutrophil infiltration by hypervirulent GAS isolates and if SpyCEP, ScpA, and SsE synergistically contribute to the inhibition of neutrophil recruitment in severe invasive infections.
Strains isolated from invasive infections have a high frequency of mutations in the two-component regulatory system CovRS (also known as CsrRS) (19, 20) , and covRS mutations also readily arise during experimental animal infections (21, 22) . Clinical isolates with a covRS mutation or deletion are usually hypervirulent. CovRS negatively regulates many virulence factors, including the capsule synthase HasA, streptolysin S, protease SpeB, DNase Sda1, IgG proteinase Mac, SpyCEP, ScpA, and SsE (13, 18, (22) (23) (24) (25) (26) . Some covR mutations enhance virulence by relieving the CovR depression of virulence factor genes (27, 28) . In contrast to the effects of CovR mutations on the expression of virulence genes, covS null mutations both up-and downregulate distinct subsets of CovRrepressed genes (26) . Loss of SpeB production and enhancement of the production of the hyaluronic acid capsule and SsE, as results of covRS mutations/deletions, are critical factors in the progression of invasive GAS infections (13, 27, 28) . Whether SpyCEP and ScpA are required for virulence and skin invasion of hypervirulent GAS isolates is not known.
We hypothesize that covS null mutation/deletion-enhanced expression of SpyCEP, ScpA, and SsE critically contributes to the enhanced innate immune evasion and virulence of GAS strains isolated from severe invasive infections. To test this hypothesis, we first performed a reciprocal analysis of the effect of covS deletion on neutrophil infiltration, virulence, and skin invasion by using two representative strains of a M1T1 subclone, MGAS5005, with a natural 1-bp deletion in covS, and MGAS2221, with the wild-type (WT) covS gene (22) . We then examined the relative and synergistic contributions of SpyCEP, ScpA, and SsE to MGAS5005 inhibition of neutrophil infiltration, virulence, and skin invasion. We found that the 1-bp deletion in covS of MGAS5005 is the cause of the that strain's enhanced innate immune evasion, skin invasion, and virulence. SsE, but not SpyCEP or ScpA, is critical for the phenotype of MGAS5005. These results provide information about the basis of GAS innate immune evasion and the progression of invasive GAS infections.
MATERIALS AND METHODS
Bacterial strains and growth. MGAS5005 and MGAS2221 are representative isolates of a prevalent M1T1 subclone from an invasive-infection case in Ontario and a scarlet fever patient in Australia, respectively (26) . The sse gene deletion mutants of MGAS5005 (MGAS5005 ⌬sse ) and MGAS2221 (MGAS2221 ⌬sse ) have been described previously (7, 13) . MGAS2221 ⌬covS has also been described previously (26) . These strains and their derivatives were grown in Todd-Hewitt broth supplemented with 0.2% yeast extract (THY) at 37°C in 5% CO 2 . Tryptose agar with 5% sheep blood and THY agar were used as solid media.
Generation of spyCEP, scpA, and sse deletion mutants. Upstream and downstream flanking fragments of an internal 301-bp fragment of the spyCEP gene (bases 100 to 400) to be deleted were amplified by PCR by using MGAS5005 genomic DNA and primer pairs 5=-TTAAGCTTGTCG GTATGCCAATTGTTC-3=/5=-TTCTCGAGCTCTGTATTGGTGAGAT GTTG-3= and 5=-TTCTCGAGTGCGCATCAGTGATGTATC-3=/5=-TTG GATCCGGATCACGTTCAATTAAAGC-3=, respectively. The upstream and downstream PCR products were sequentially cloned into pGRV (29) at the HindIII/XhoI and XhoI/BamHI sites, respectively, producing p⌬spyCEP. To delete a 1,240-bp fragment of the scpA gene (bases 357 to 1410), p⌬scpA was similarly constructed by using primer pairs 5=-AGGA TCCGTCAATCACAGCTTCCACTTG-3=/5=-ACTCGAGAACAGTCCC AGCTCCTTTG-3= and 5=-ACTCGAGCAAAAGCAATATGAGACACA G-3=/5=-AAGATCTCAACATTTCCTTCTTTGTCC-3= and the BamHI/ XhoI and XhoI/BgIII sites of pGRV. p⌬sse, which was used to delete the sse gene from the ⌬spyCEP, ⌬scpA, and ⌬spyCEP ⌬scpA mutants of MGAS5005, has been described previously (13) .
These plasmids were used to generate single deletion mutants MGAS5005 ⌬spyCEP , MGAS2221 ⌬spyCEP , MGAS5005 ⌬scpA , and MGAS2221 ⌬scpA and spyCEP, scpA, and sse gene double and triple deletion mutants of MGAS5005 (⌬spyCEP ⌬scpA, ⌬spyCEP ⌬sse, ⌬scpA ⌬sse, and ⌬scpA ⌬spyCEP ⌬sse mutants) by following the procedure that was used to generate the ⌬sse mutant of MGAS5005 (13) . All of the mutants were confirmed by PCR and DNA sequencing. PCR confirmation of the spyCEP and scpA deletions was done with primer pairs 5=-GTTAA AACATTTAGGAGGG-3=/5=-GTATTTGGTGTCATCGTCTG-3=; and 5=-CCTGCTACCGAACAAGCTG-3=/5=-CTTTATCTGTCACATACAT CG-3=, respectively. The deletion of spyCEP was further confirmed by Western blotting in which the smaller fragment of mature SpyCEP was extracted from GAS bacteria by using a saturated urea solution and detected by Western blotting using polyclonal rabbit antibodies raised against recombinant SP24F1, which was part of SpyCEP and was previously described (30 GAS bacteria grown to mid-exponential phase in THY were harvested by centrifugation, washed three times with pyrogen-free Dulbecco's phosphate-buffered saline (DPBS), and resuspended in DPBS in the desired doses. Because outbred CD-1 Swiss mice were cheaper than BALB/c mice while MGAS5005 shows similar inhibition of neutrophil recruitment in both CD-1 and BALB/c mice, we used outbred, 5-week-old CD-1 female mice from Charles River Laboratories in this study. Groups of 5 or 10 mice were subcutaneously infected with 0.2 ml of GAS suspension with an optical density at 600 nm (OD 600 ) of 0.9 or about 10 8 CFU of MGAS5005 and/or their isogenic mutant in 0.2 ml DPBS with an OD 600 slightly higher or lower than 0.9, depending on the mutant. Actual inocula were determined by plating. For virulence comparisons, infected mice were monitored daily for 14 days to determine survival rates. For other analyses, mice infected were euthanized at 24 h after inoculation to collect skin, liver, and spleen samples. Liver and spleen samples were homogenized in DPBS by using a Kontes pestle. GAS bacterial numbers in the homogenized samples were determined by plating. To measure lesion sizes and neutrophil recruitment, the skin around the infection site was peeled off and the whole infection area was recognized by the boundary of the inflammation and excised; the area was traced on paper for measurement of the infection area by weighing the traced paper.
Quantification of neutrophil infiltration. Numbers of recruited neutrophils in the excised skin were estimated by the myeloperoxidase assay as described previously (7, 32) . Skin samples were ground in 0.5% hexadecyltrimethylammonium bromide in 50 mM potassium and sonicated on ice for 15 s to extract myeloperoxidase. The samples were frozen and thawed three times, sonicated, and centrifuged at 16,000 ϫ g for 5 min, resulting in the supernatant for the following myeloperoxidase assay. The supernatant was added to 0.2 ml of 50 mM phosphate buffer, pH 6.0, containing the extracted myeloperoxidase, 0.167 mg/ml o-dianisidine dihydrochloride, and 0.001% hydrogen peroxide, and the change in absorption at 460 nm (⌬A 460 ) with time was recorded with a SPECTRAmax 384 Plus spectrophotometer (Molecular Devices). The myeloperoxidase activity, ⌬A 460 /min, was converted into the number of neutrophils by using a standard curve of myeloperoxidase activities versus known numbers of murine neutrophils isolated from bone marrow as previously described (33) .
Histological analyses. Skin infection sites were excised with a wide margin after the skin was peeled off and fixed in 10% neutral buffered formalin for 24 h. The samples were dehydrated with ethanol, cleared with xylene, and infiltrated with paraffin using a Tissue Embedding Console System (Sakura Finetek, Inc.). The paraffin blocks was processed to obtain 4-m sections, which were stained with hematoxylin and eosin (H&E) or with a tissue Gram stain kit from Richard-Allan Scientific according to the manufacturer's protocol. Stained samples were examined by using a Nikon ECLIPSE 80i microscope.
GAS competitive growth assay. A 0.2-ml volume of a 1:1 MGAS5005 ⌬spyCEP -MGAS5005, MGAS5005 ⌬scpA -MGAS5005, or ⌬spyCEP ⌬scpA ⌬sse-⌬spyCEP ⌬scpA mutant mixture with 0.8 ml air was injected subcutaneously into mice. The mice were euthanized at 24 h after inoculation, and the air sac was lavaged with 1 ml PBS. The lavage samples were plated on THY agar plates. The ratio of the two strains in each lavage sample was determined by analyzing 48 colonies of each sample by colony PCR. The primers used to check ⌬spyCEP/WT and ⌬scpA/WT ratios were those that were used to confirm the spyCEP and scpA deletions. The primers used to check the ⌬spyCEP ⌬scpA ⌬sse/⌬spyCEP ⌬scpA mutant ratio were 5=-AT AACATTTACATTAAGGAGATAC-3= and 5=-CAGATTTGGTGTTTGA AAAAG-3=. In each PCR analysis, the PCR product of deletion mutant was smaller than that of the corresponding WT strain. The mutant/WT GAS ratio in the inoculum was determined by plating the individual GAS suspension prior to mixing. The competitive index was calculated by dividing the mutant/WT GAS ratio in the lavage samples by the ratio in the inoculum.
Other assays. Quantitative reverse transcription (RT)-PCR analysis for spyCEP, hasA, and sse mRNAs was performed with a specific probe and gyrA as a control, as previously described (13) . SpeB activity in the supernatant of overnight GAS cultures was detected by using the casein plate assay as previously described (34) .
Statistical analyses. The Prism software program (GraphPad Software, Inc.) was used for all statistical analyses. Survival data were analyzed by using the log-rank (Mantel-Cox) test. The data in Fig. 4C and D were analyzed by a one-way analysis of variance (ANOVA) Newman-Keuls multiple-comparison test. The data in Fig. 6 were analyzed using onetailed Student t test. Other P values were obtained by using the two-tailed Mann-Whitney t test.
RESULTS
Distinct neutrophil responses in subcutaneous MGAS2221 and MGAS5005 infections. Although MGAS2221 and MGAS5005 have almost identical genetic contents (22) , they display distinct phenotypes in subcutaneous infections of mice. Inside-out pictures of MGAS5005 and MGAS2221 infection sites display distinct overall pathologies with a greater infection area and less pus-like infiltrate for MGAS5005 than for MGAS2221 (Fig. 1A and B) . Myeloperoxidase measurements found that MGAS2221 induced 25-fold greater neutrophil recruitment at the skin infection site than MGAS5005 did [mean neutrophil number Ϯ standard deviation (SD): MGAS5005, (5.6 Ϯ 1.4) ϫ 10 3 neutrophils/mm 2 ; MGAS2221, (1.4 Ϯ 0.8) ϫ 10 5 neutrophils/mm 2 (P ϭ 0.0046)] (Fig. 1C) . The mean skin lesion size Ϯ SD caused by MGAS5005 at 24 h after inoculation was 397 Ϯ 27 mm 2 , which was 4.7-fold larger than the lesion size caused by MGAS2221 (85 Ϯ 35 mm 2 ) (P Ͻ 0.0001) (Fig. 1D) . Consequently, MGAS5005 is more virulent than MGAS2221 in the skin infection model (Fig. 1E) . The more severe infection phenotype of MGAS5005 is not due to a growth advantage because MGAS2221 grows faster than MGAS5005 in THY (Fig. 1F) .
CovRS regulates inhibition of neutrophil infiltration. Although MGAS5005 and MGAS2221 have almost identical genomes, MGAS5005 has a 1-bp deletion at base 83 of the covS gene, whereas MGAS2221 has the WT covS gene (22) . To determine whether the 1-bp deletion in covS of MGAS5005 causes the distinct phenotypes of MGAS5005 and MGAS2221, we first knocked out the covS ⌬1bp pseudogene of MGAS5005 and then knocked in the WT covS gene, resulting in MGAS5005
WTcovS . covS null mutations cause loss of SpeB production (35, 36) . MGAS5005 does not have detectable SpeB activity in vitro (13) , and SpeB production should be restored if covS WT is successfully knocked in. Indeed, MGAS5005
WTcovS , like MGAS2221, produced detectable SpeB activity ( Fig. 2A) . The transcription of spyCEP, sse, and hasA in MGAS5005
WTcovS was 40-, 50-, and 133-fold lower than that in MGAS5005, respectively, and was similar to that in MGAS2221 (Fig. 2B) , further confirming the replacement of covS ⌬1bp with covS WT . Thus, we successfully replaced covS ⌬1bp of MGAS5005 with the WT covS gene.
Next, we compared MGAS5005 and MGAS5005 WTcovS for virulence, skin invasion, and neutrophil recruitment in subcutaneous infections of mice. Most of the mice infected with MGAS5005 died, whereas all of the mice infected with MGAS5005
WTcovS survived (P ϭ 0.0012) (Fig. 2C) . At 1 day after inoculation, the area of MGAS5005 WTcovS infection sites (76.5 Ϯ 8 mm 2 ) was 90% smaller than that of MGAS5005 infection sites (786 Ϯ 82 mm 2 ) (P Ͻ 0.0001) but was similar to that of MGAS2221 infection sites (85.5 Ϯ 15.9 mm 2 ) (P ϭ 0.63) (Fig. 2F ). In addition, the GAS load in the spleens of mice infected with MGAS5005
WTcovS was 4.6 Each culture at the mid-exponential growth phase was diluted at time zero to start measurements of OD 600 over time.
orders of magnitude lower than that in the spleens of MGAS5005-infected mice but was similar to that in the spleens of MGAS2221-infected mice (Fig. 2E) . 3 neutrophils/mm 2 ) (P ϭ 0.4000) (Fig. 2D) . The size of the MGAS2221 ⌬covS infection sites (637 Ϯ 107 mm 2 ) was 7-fold larger than that of the MGAS2221 sites (85.5 Ϯ 15.9 mm 2 ) (P ϭ 0.0006) and similar to that of MGAS5005 infection sites (786 Ϯ 82 mm 2 ) (P ϭ 0.2100) (Fig. 2F) . While the lesion sizes of MGAS2221 infections in Fig. 1D and 2F were similar, the lesion sizes of MGAS5005 infections in the two experiments were different. This difference was most likely due to the fluctuation of the actual inoculum size. An MGAS5005 suspension with an OD 600 of 0.9 was used in both experiments, but the number of viable MGAS5005 bacteria in the inoculum for Fig. 2F was approximately 10% higher than that in the inoculum for Fig. 1D . Despite this difference, these results clearly indicate that the phenotype of MGAS5005 in skin infections is caused by the covS null deletion and that CovRS negatively regulates the inhibition of neutrophil recruitment by GAS.
Relative contributions of SpyCEP, ScpA, and SsE to MGAS5005 skin invasion, virulence, and inhibition of neutrophil recruitment. Since the expression of spyCEP, scpA, and sse is enhanced by the covS deletion in MGAS5005, we hypothesize that SpyCEP, ScpA, and SsE contribute to the MGASA5005 phenotype. We first tested this hypothesis by determining the relative contributions of these hydrolases to MGAS5005 skin invasion, virulence, and inhibition of neutrophil recruitment. We deleted a 301-bp fragment of the spyCEP gene and a 1,240-bp fragment of the scpA gene. The mutants were identified by PCR and confirmed by DNA sequencing (data not shown). SpyCEP was detected in MGAS5005 by Western blotting but was not found in the ⌬spyCEP mutant, confirming the spyCEP deletion (data not shown). Both the spyCEP and scpA deletion mutants produced the M protein at levels that were similar to that produced by MGAS5005, as judged by Western blotting (data not shown). MGAS5005 ⌬spyCEP and MGAS5005 ⌬scpA had competitive growth indexes of 0.78 and 0.94, respectively, against MGAS5005 in a mouse air sac infection model. Thus, the deletion of spyCEP or scpA did not have a growth issue or substantially alter emm expression. The competitive growth result of the ⌬spyCEP mutant confirms the previous results (10, 37) .
The MGAS5005 ⌬spyCEP and MGAS5005 ⌬scpA mutants were compared in subcutaneous infections of mice with the parent strain MGAS5005 and its ⌬sse mutant. MGAS5005 ⌬spyCEP , MGAS5005
⌬scpA , and MGAS5005 infection sites had similar overall pathology, showing extensive GAS spreading and inflammation, whereas the MGAS5005 ⌬sse site was small and appeared to have robust inflammatory cell infiltrate (Fig. 3) ⌬spyCEP had a zone of scattered neutrophils at the inner side of the skin (the left side of Fig. 5A and B), which was followed by a band of amorphous material and then by a GAScontaining area (Fig. 5A and B) . The bacterial territory had no neutrophils. This pattern is the same as one that was recently described at MGAS5005 infection sites (7) . At the spread area, there were sparse neutrophils in both MGAS5005 (Fig. 5C and D) and MGAS5005 ⌬spyCEP ( Fig. 5E and F) infections. This pattern of GAS and neutrophil distribution in MGAS5005 and MGAS5005 ⌬spyCEP is different from that in MGAS5005 ⌬sse infection sites, where neutrophils march into the area containing bacteria (Fig. 5G and F) .
The histological findings on MGAS5005
⌬sse infection of CD-1 mice confirm our previous findings on MGAS5005 ⌬sse infection of BALB/c mice (7) . These data further indicate that SsE, but not SpyCEP, plays a critical role in innate immune evasion by MGAS5005.
No synergistic effect of SsE, SpyCEP, and ScpA on MGAS5005 inhibition of neutrophil infiltration. Although SpyCEP and ScpA do not individually contribute to MGAS5005 inhibition of neutrophil recruitment, they may have additive effects on innate immune evasion and thus virulence and skin invasion. To test this idea, we also generated double and triple spyCEP, scpA, and sse mutants of MGAS5005. The sse gene was deleted after the spyCEP and/or scpA genes were deleted to obtain the double and triple mutants. The ⌬spyCEP ⌬scpA ⌬sse triple mutant had a competitive index of 0.98 against the ⌬spyCEP ⌬scpA double mutant (data not shown), indicating that the sse deletion in the background of no spyCEP or scpA had no effect on in vivo growth. The ⌬spyCEP ⌬scpA double deletion mutant induced (2.8 Ϯ 1.4) ϫ 10 4 neutrophils/mm 2 and caused lesions of (341 Ϯ 43) mm 2 , and these results were not significantly different from those of infections with MGAS5005, MGAS5005
⌬spyCEP , and MGAS5005 ⌬scpA (Fig. 4D) . The virulence of the ⌬spyCEP ⌬scpA mutant was similar to that of MGAS5005, MGAS5005 ⌬spyCEP , and MGAS5005 ⌬scpA as well (P ϭ 0.6675 versus the WT, P ϭ 0.5161 versus the ⌬spyCEP mutant, and Pϭ 0.6478 versus the ⌬scpA mutant) (Fig. 4A and B) .
In contrast, the ⌬spyCEP ⌬sse, ⌬scpA ⌬sse, and ⌬spyCEP ⌬scpA ⌬sse mutants all induced significantly higher levels of neutrophil recruitment (Fig. 4D) , caused significantly larger lesions (Fig. 4C) , and had significantly attenuated virulence ( Fig. 4A and B ) compared with MGAS5005 and its spyCEP and scpA single and double deletion mutants. In addition, the ⌬spyCEP ⌬sse mutant caused significantly larger lesions than the ⌬sse and ⌬scpA ⌬sse mutants did, suggesting that the spyCEP deletion in the absence of the sse gene enhanced the invasion of skin by MGAS5005. All of these results indicate that SpyCEP and ScpA did not additively contribute to a reduction of neutrophil infiltration by SsE.
Effects of sse, spyCEP, and scpA deletions on MGAS2221 skin invasion and inhibition of neutrophil recruitment. The data on MGAS5005 inhibition of neutrophil recruitment suggest that CovRS regulates the inhibition of neutrophil recruitment and that SsE is an important factor in this regulation. To determine whether these findings are applicable to GAS with intact CovRS, we constructed MGAS2221 ⌬spyCEP and MGAS2221 ⌬scpA and compared them with MGAS2221 and MGAS2221 ⌬sse for skin invasion and neutrophil infiltration in subcutaneous infections of CD-1 mice. All of these mutants had normal M protein production according to Western blotting (data not shown). MGAS2221 ⌬sse induced (6.5 Ϯ 2.8) ϫ 10 5 neutrophils/mm 2 , which was 80% higher than the (3.6 Ϯ 1.2) ϫ 10 5 neutrophils/mm 2 at MGAS2221 infection sites (P ϭ 0.0340), whereas the levels of neutrophils at MGAS2221 ⌬spyCEP ([4.0 Ϯ 1.1] ϫ 10 5 neutrophils/mm 2 ; P ϭ 0.3068) and MGAS2221
⌬scpA ([4.5 Ϯ 1.1] ϫ 10 5 neutrophils/mm 2 ; P ϭ 0.1225) infection sites were not significantly different from those at MGAS2221 infection sites (Fig. 6B) . Deletion of the sse gene slightly decreased the lesion size in CD-1 mice, but the difference was not statistically significant. Deletion of scpA had no effect on skin invasion, whereas deletion of spyCEP significantly increased lesion size (Fig. 6A) , confirming previous findings (11) . These data indicate that the findings on invasive GAS isolates with nonfunctional CovRS regulation are qualitatively applicable to GAS with intact CovRS. Our results also suggest that CovRS can regulate neutrophil recruitment by regulating the sse gene.
DISCUSSION
This report describes two findings on the innate immune evasion of GAS: (i) the natural covS null deletion in MGAS5005 confers its innate immune evasion phenotype, and (ii) SsE is a dominant factor in MGAS5005 evasion of innate immunity, and SpyCEP and ScpA alone and in combination do not significantly contribute to the inhibition of neutrophil infiltration of MGAS5005. In addition, the relative contributions of SsE, SpyCEP, and ScpA to the inhibition of neutrophil recruitment is correlated with their relative importance for GAS virulence and skin invasion, suggesting that reduced neutrophil ingress is a critical factor in hypervirulence and skin invasion. These findings provide insight into the molecular basis of the regulation of innate immune evasion by CovRS and innate immune evasion by hypervirulent M1T1 GAS isolates. Sparse neutrophil infiltrate has been documented in necrotizing fasciitis patients (3) (4) (5) . This phenotype of innate immune evasion can be mimicked in the mouse model of necrotizing fasciitis using invasive isolates (3, 7) but not pharyngitis isolates (7) . A novel finding of this study is that covS deletion can result in the phenotype of the severe innate immune evasion, which is correlated with the severity of skin invasion and hypervirulence. This finding indicates that CovRS regulates the inhibition of neutrophil infiltration and covRS null mutations maximize the inhibition of neutrophil infiltration by releasing CovRS repression of virulence factors involved in innate immune evasion. Thus, covS null mutation-enhanced inhibition of neutrophil recruitment is an addition to the list of the determinants of CovRS mutation-mediated progression of invasive GAS infection, which include loss of SpeB production and enhanced production of the hyaluronic acid capsule and DNase Sda1 in covS null mutants (18, 27, 28) .
The spyCEP and sse genes are negatively regulated by CovRS. Deletion of covS enhances the expression of spyCEP and sse by Ն40-fold (Fig. 2B) , confirming the previous observations (13, 38) . Even though scpA is regulated by the positive regulator Mga (39), its expression is also upregulated by covS deletion (22) . Thus, the relief of the CovR repression of inhibitors of neutrophil infiltration as a result of covS null mutations is expected to be the reason for the sparse neutrophil infiltrate in hypervirulent GAS infections. We previously showed that deletion of sse enhances neutrophil recruitment and the function of SsE is partly mediated by its platelet-activating factor acetylhydrolase activity (7) . Thus, it is not surprising that deletion of sse from ⌬spyCEP, ⌬scpA, and 8 CFU ⌬scpA ⌬spyCEP ⌬sse mutant bacteria. One-way ANOVA of the PMN data: not significant, all pairs among MGAS5005 and the ⌬spyCEP, ⌬scpA, and ⌬spyCEP ⌬scpA mutants and pairs among the strains carrying ⌬sse; significant, all of the other pairs. One-way ANOVA of the lesion data: not significant, the ⌬sse mutant versus the ⌬scpA ⌬sse mutant, the ⌬spyCEP ⌬scpA ⌬sse mutant versus the ⌬spyCEP ⌬sse mutant, MGAS5005 versus the ⌬spyCEP mutant, MGAS5005 versus the ⌬scpA mutant, MGAS5005 versus the ⌬spyCEP ⌬scpA mutant, the ⌬spyCEP ⌬scpA mutant versus the ⌬spyCEP mutant, the ⌬spyCEP ⌬scpA mutant versus the ⌬scpA mutant, and the ⌬scpA mutant versus the ⌬spyCEP mutant; significant, all of the other pairs. ⌬spyCEP ⌬scpA mutants enhanced neutrophil recruitment. However, it is unexpected that SpyCEP and ScpA, both alone and in combination, did not significantly contribute to the inhibition of neutrophil recruitment and SsE is a dominant factor in MGAS5005 inhibition of neutrophil infiltration. Nonetheless, it appears to be true that the relief of CovRS repression of the sse gene as a result of the covS deletion critically contributes to the inhibition of neutrophil recruitment. Deletion of sse, but not spyCEP or scpA, of MGAS2221 significantly enhanced neutrophil recruitment, supporting the idea that the findings associated with invasive GAS isolates with nonfunctional CovRS regulation are qualitatively applicable to GAS with intact CovRS. ScpA degrades the C5a peptide, and immunization with ScpA prevents nasopharyngeal GAS colonization of mice (40) . However, scpA deletion does not affect GAS virulence in subcutaneous infection of mouse tissue (41) . Therefore, the insignificant contribution of ScpA to MGAS5005 inhibition of neutrophil recruitment, virulence, and skin invasion is not surprising. However, the insignificant involvement of SpyCEP in MGAS5005 innate immune evasion is a surprise. SpyCEP degrades IL-8/CXC chemokines (3, 8, 10, 11, 36, 42) . This protein reduces IL-8/CXC-induced neutrophil transmigration in vitro (10, 19) and confers resistance of GAS to killing by isolated neutrophils (10) . Three studies have investigated the contribution of SpyCEP to GAS pathogenesis and inhibition of neutrophil infiltration by using the mouse model of subcutaneous infection, proposing that SpyCEP contributes to the inhibition of neutrophil recruitment (3, 10, 11) . However, these studies lack quantitative data on the effect of spyCEP deletion on neutrophil ingress into GAS infection sites. Furthermore, a single spyCEP deletion mutant was not available for one of these studies (3). Thus, whether SpyCEP is a critical factor in GAS inhibition of neutrophil recruitment has not been firmly established. Our quantitative analyses of neutrophil ingress indicate that SpyCEP is dispensable to the inhibition of neutrophil recruitment by the hypervirulent M1T1 isolate. Our results suggest that SpyCEP is not critical for covS null mutation/deletioninduced enhancement of the inhibition of neutrophil recruitment.
Sumby et al. found that skin lesion size was increased following infection with a ⌬spyCEP mutant of MGAS2221, a M1T1 isolate with the covRS genes intact (11) . Our test, which used MGAS2221 and our own MGAS2221 ⌬spyCEP mutant, confirmed the findings of Sumby et al. In a similar dermonecrosis model, two other groups found that the lesion size was reduced with a spyCEP mutant (3, 10) . The discrepancy could be due to the use of different mice and GAS isolates in these studies. Although the deletion of spyCEP in MGAS5005 did not significantly affect lesion size, the deletion of spyCEP in sse-lacking MGAS5005 significantly increased skin invasion. The impact of the spyCEP deletion on skin invasion by MGAS5005 could be masked by the high capacity of MGAS5005 to invade skin. Sumby et al. proposed that the increased lesion size in a ⌬spyCEP mutant infection is caused by enhanced neutrophil infiltration as a result of spyCEP deletion (11) . Our neutrophil influx data are not consistent with this proposal, suggesting that SpyCEP has another functional mechanism in addition to IL-8/ CXC degradation. SpyCEP has been shown to be sufficient for GAS dissemination in mouse models of muscular and intranasal infections by heterologous expression of SpyCEP in Lactococcus lactis (42) . The enhanced skin invasion in the absence of SpyCEP and the persistence of SpyCEP-expressing L. lactis might be due to another function of SpyCEP in promoting GAS uptake by endothelial cells (43) .
MGAS5005 grows more slowly than MGAS2221 in vitro. This growth difference is likely due to the higher consumption of energy because of the enhanced production of virulence factors by MGAS5005 as a result of the covS deletion. Although MGAS2221 grows faster, it is less virulent than MGAS5005. Thus, the ability to evade the innate immune system for in vivo survival appears to be more important for GAS virulence than the capacity to grow.
In summary, a natural covS null deletion is shown to greatly enhance the inhibition of neutrophil infiltration, skin invasion, and GAS dissemination, and Sse, but not SpyCEP or ScpA, plays a dominant role in the covS deletion-caused enhancement of GAS inhibition of neutrophil infiltration, skin invasion, and virulence. The findings indicate that CovRS regulates neutrophil infiltration and that covS deletion-enhanced expression of sse, but not the enhanced expression of spyCEP, is a critical factor in the severe inhibition of neutrophil recruitment and hypervirulence, thereby advancing our understanding of the molecular basis of innate immune evasion by GAS and the progression of invasive GAS infections.
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